@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BTC53WWM-1
  skos:prefLabel "Inhibiteurs du cytochrome P-450 CYP2D6"@fr, "Cytochrome P-450 CYP2D6 Inhibitors"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FBL18KL1-7
  skos:prefLabel "Serotonin Uptake Inhibitors"@en, "Inhibiteurs de la capture de la sérotonine"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-HS4F8NLG-H
  mesh:allowableQualifier jvr:-W6SQV79N-S, jvr:-NFTHND7Q-8, jvr:-G30ZJ446-J, jvr:-L6C0XPHT-4, jvr:-R3QWLHRG-V, jvr:-BT300B3G-Q, jvr:-S0CS1X5R-5, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3, jvr:-H7K65Q8S-Z, jvr:-FWD2BGQ0-9, jvr:-D0F21513-5, jvr:-R0ZCQ8X6-J, jvr:-NKM836P1-M, jvr:-NHL3D2X0-S, jvr:-HQRFT0C6-B, jvr:-SBNWSM1T-R, jvr:-TJHVZCRZ-0, jvr:-WK5F724J-1, jvr:-NB0XHT3S-N, jvr:-M63HSDM7-1, jvr:-XV06LPML-W, jvr:-G4R176S9-J, jvr:-Q3979798-W, jvr:-T9HQD7ST-J ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D005473> ;
  a mesh:Descriptor, skos:Concept ;
  dc:established "1989-01-01"^^xsd:date ;
  skos:altLabel "I9W7N6B1KJ"@fr, "I9W7N6B1KJ"@en, "59333-67-4 (HCl)"@fr, "59333-67-4 (HCl)"@en, "54910-89-3 (Fluoxetine)"@en, "54910-89-3 (Fluoxetine)"@fr, "01K63SUP8D"@fr, "01K63SUP8D"@en, "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine"@en, "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-"@fr, "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-"@en, "Fluoxetin"@en ;
  dc:modified "2014-06-17"^^xsd:date ;
  dc:created "1977-12-09"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-X5BRM0BB-H, jvr:-FBL18KL1-7, jvr:-BTC53WWM-1 ;
  skos:hiddenLabel "Prozac"@en, "Fluoxetine Hydrochloride"@en, "Chlorhydrate de fluoxétine"@fr, "Lilly110140"@fr, "Sarafem"@en, "Lilly-110140"@fr, "Lilly-110140"@en ;
  skos:definition "The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants."@en ;
  skos:broader jvr:-F0J1G7T1-0 ;
  skos:prefLabel "Fluoxétine"@fr, "Fluoxetine"@en ;
  skos:inScheme jvr: .

jvr:-X5BRM0BB-H
  skos:prefLabel "Antidépresseurs de seconde génération"@fr, "Antidepressive Agents, Second-Generation"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-F0J1G7T1-0
  skos:prefLabel "Propylamines"@fr, "Propylamines"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-HS4F8NLG-H .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .